These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38756999)

  • 1. Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).
    Rivera JC; Espinoza-Derout J; Hasan KM; Molina-Mancio J; Martínez J; Lao CJ; Lee ML; Lee DL; Wilson J; Sinha-Hikim AP; Friedman TC
    Front Endocrinol (Lausanne); 2024; 15():1282231. PubMed ID: 38756999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
    Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
    Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation.
    Mock K; Lateef S; Benedito VA; Tou JC
    J Nutr Biochem; 2017 Jan; 39():32-39. PubMed ID: 27768909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling.
    Hasan MK; Friedman TC; Sims C; Lee DL; Espinoza-Derout J; Ume A; Chalfant V; Lee ML; Sinha-Hikim I; Lutfy K; Liu Y; Mahata SK; Sinha-Hikim AP
    Endocrinology; 2018 Feb; 159(2):931-944. PubMed ID: 29272360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
    Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis.
    Salic K; Gart E; Seidel F; Verschuren L; Caspers M; van Duyvenvoorde W; Wong KE; Keijer J; Bobeldijk-Pastorova I; Wielinga PY; Kleemann R
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway.
    Wang S; Wan T; Ye M; Qiu Y; Pei L; Jiang R; Pang N; Huang Y; Liang B; Ling W; Lin X; Zhang Z; Yang L
    Redox Biol; 2018 Jul; 17():89-98. PubMed ID: 29679894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated transcriptome and metabolome study reveal the therapeutic effects of nicotinamide riboside and nicotinamide mononucleotide on nonalcoholic fatty liver disease.
    Zhang J; Chen F
    Biomed Pharmacother; 2024 Jun; 175():116701. PubMed ID: 38729053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model.
    Joshi U; Evans JE; Pearson A; Saltiel N; Cseresznye A; Darcey T; Ojo J; Keegan AP; Oberlin S; Mouzon B; Paris D; Klimas N; Sullivan K; Mullan M; Crawford F; Abdullah L
    Neurotoxicology; 2020 Jul; 79():84-94. PubMed ID: 32343995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP
    Mejía SÁ; Gutman LAB; Camarillo CO; Navarro RM; Becerra MCS; Santana LD; Cruz M; Pérez EH; Flores MD
    Eur J Pharmacol; 2018 Jan; 818():499-507. PubMed ID: 29069580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex-specific manner.
    Bhat SF; Pinney SE; Kennedy KM; McCourt CR; Mundy MA; Surette MG; Sloboda DM; Simmons RA
    J Physiol; 2021 Mar; 599(5):1487-1511. PubMed ID: 33450094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice.
    Kim MB; Pham TX; vanLuling M; Kostour V; Kang H; Corvino O; Jang H; Odell W; Bae M; Park YK; Lee JY
    J Nutr Biochem; 2022 Sep; 107():109058. PubMed ID: 35643283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.
    Gariani K; Menzies KJ; Ryu D; Wegner CJ; Wang X; Ropelle ER; Moullan N; Zhang H; Perino A; Lemos V; Kim B; Park YK; Piersigilli A; Pham TX; Yang Y; Ku CS; Koo SI; Fomitchova A; Cantó C; Schoonjans K; Sauve AA; Lee JY; Auwerx J
    Hepatology; 2016 Apr; 63(4):1190-204. PubMed ID: 26404765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
    Collison KS; Maqbool ZM; Inglis AL; Makhoul NJ; Saleh SM; Bakheet RH; Al-Johi MA; Al-Rabiah RK; Zaidi MZ; Al-Mohanna FA
    Obesity (Silver Spring); 2010 Jun; 18(6):1122-34. PubMed ID: 20111022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes.
    Loza-Medrano SS; Baiza-Gutman LA; Manuel-Apolinar L; García-Macedo R; Damasio-Santana L; Martínez-Mar OA; Sánchez-Becerra MC; Cruz-López M; Ibáñez-Hernández MA; Díaz-Flores M
    Mol Biol Rep; 2020 Jan; 47(1):337-351. PubMed ID: 31650383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
    Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
    J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD
    Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
    Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
    [No Abstract]   [Full Text] [Related]  

  • 20. Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice.
    Friedman TC; Sinha-Hikim I; Parveen M; Najjar SM; Liu Y; Mangubat M; Shin CS; Lyzlov A; Ivey R; Shaheen M; French SW; Sinha-Hikim AP
    Endocrinology; 2012 Dec; 153(12):5809-20. PubMed ID: 23093702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.